IP Verse

Laboratorios Pfizer vs. Glaxosmithkline - UPC_CFI_687/2024

The case UPC_CFI_687/2024 was filed by the plaintiff Laboratorios Pfizer, Pfizer against the defendant Glaxosmithkline Biologicals on 15 Nov, 2024.

Case Timeline

15 Nov, 2024
Case Filed
15 Nov, 2024
Counterclaim for Revocation
Today Nov 1, 2025
Reply Filed
Written Procedure
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_687/2024

    Patent Number:

    EP4183412

    Filing Date:

    15 Nov, 2024

    Proceeding Type:

    Counter Claim For Revocation

    Case Phase:

    Case Closed

    Plaintiffs:

    • Laboratorios Pfizer
    • Pfizer
    • Pfizer AB
    • Pfizer Austria
    • Pfizer Luxembourg

    Plaintiff Representative:

    • Gareth Williams

    Defendants:

    • Glaxosmithkline Biologicals

    Defendant Representative:

    • Oliver Jan JÜNGST

    Judges:

    • Andrea Postiglione
    • Anna-Lena Klein
    • Steen Lyders Wadskov-Hansen

    Court Division:

    First Instance, Central Division - Milan

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Apr 28, 2025Case Closure Formal Check
Apr 22, 2025Template Order
Apr 22, 2025Outcome Of The Order
Apr 22, 2025Order On Request To Withdraw
Apr 11, 2025Receipt
Apr 11, 2025250411 Withdrawal Of Application To Amend
Apr 10, 2025Receipt
Apr 10, 2025Application For Leave To Withdraw An Action
Mar 14, 2025Panel Appointment
Mar 14, 2025Extension Reply Counterclaim
Feb 26, 2025Panel Appointment
Jan 14, 2025Formal Checks Notification Of Positive Outcome
Jan 14, 2025Acknowledgement Of Lodging
Jan 13, 2025Formal Checks Notification Of Positive Outcome
Jan 13, 2025D44 4
Jan 13, 2025D44 3
Jan 13, 2025D44 2
Jan 13, 2025D44 1
Jan 13, 2025D43
Jan 13, 2025D42
Jan 13, 2025D41
Jan 13, 2025D40
Jan 13, 2025D39
Jan 13, 2025D38
Jan 13, 2025D37
Jan 13, 2025D36
Jan 13, 2025D35
Jan 13, 2025D34
Jan 13, 2025D33 3
Jan 13, 2025D33 2
Jan 13, 2025D33
Jan 13, 2025D32
Jan 13, 2025D31
Jan 13, 2025D30
Jan 13, 2025D29
Jan 13, 2025D28
Jan 13, 2025D27
Jan 13, 2025D26
Jan 13, 2025D25
Jan 13, 2025D24
Jan 13, 2025D23
Jan 13, 2025D22
Jan 13, 2025D21
Jan 13, 2025D20
Jan 13, 2025D19
Jan 13, 2025D18 2
Jan 13, 2025D18 1
Jan 13, 2025D17 2
Jan 13, 2025D17 1
Jan 13, 2025D16
Jan 13, 2025D15
Jan 13, 2025D14
Jan 13, 2025D13
Jan 13, 2025D12
Jan 13, 2025D11
Jan 13, 2025D10
Jan 13, 2025D09 2
Jan 13, 2025D09 1
Jan 13, 2025D08
Jan 13, 2025D07
Jan 13, 2025D06
Jan 13, 2025D05
Jan 13, 2025Bb24
Jan 13, 2025Bb22
Jan 13, 2025Bb 22
Jan 13, 2025Bb18
Jan 13, 2025Bb17
Jan 13, 2025Bb16
Jan 13, 2025Acknowledgement Of Lodging
Jan 13, 2025250113 Defence To Counterclaim 60908 2024 And Application To Amend
Jan 13, 2025250113 Defence To Counterclaim 60908 2024
Nov 20, 2024Communicationcheck
Nov 19, 2024Zustellung Cc Claxo Smithkline
Nov 19, 2024Notification Of Service
Nov 19, 2024Document From Epo
Nov 15, 2024Panel Appointment
Nov 15, 2024Letter For Service
Nov 15, 2024Formal Checks Notification Of Positive Outcome
Nov 15, 2024Exhibit Ww 10
Nov 15, 2024Exhibit Ww 09
Nov 15, 2024Exhibit Ww 08
Nov 15, 2024Exhibit Ww 07
Nov 15, 2024Exhibit Ww 06
Nov 15, 2024Exhibit Ww 05
Nov 15, 2024Exhibit Ww 04
Nov 15, 2024Exhibit Ww 03
Nov 15, 2024Exhibit Ww 02
Nov 15, 2024Exhibit Ww 01
Nov 15, 2024Exhibit Pf 9
Nov 15, 2024Exhibit Pf 8
Nov 15, 2024Exhibit Pf 7
Nov 15, 2024Exhibit Pf 6
Nov 15, 2024Exhibit Pf 5
Nov 15, 2024Exhibit Pf 5
Nov 15, 2024Exhibit Pf 46
Nov 15, 2024Exhibit Pf 45
Nov 15, 2024Exhibit Pf 44
Nov 15, 2024Exhibit Pf 43
Nov 15, 2024Exhibit Pf 42
Nov 15, 2024Exhibit Pf 41
Nov 15, 2024Exhibit Pf 40
Nov 15, 2024Exhibit Pf 4
Nov 15, 2024Exhibit Pf 4
Nov 15, 2024Exhibit Pf 4
Nov 15, 2024Exhibit Pf 39
Nov 15, 2024Exhibit Pf 38
Nov 15, 2024Exhibit Pf 37
Nov 15, 2024Exhibit Pf 36
Nov 15, 2024Exhibit Pf 35
Nov 15, 2024Exhibit Pf 34
Nov 15, 2024Exhibit Pf 33
Nov 15, 2024Exhibit Pf 32
Nov 15, 2024Exhibit Pf 31
Nov 15, 2024Exhibit Pf 30
Nov 15, 2024Exhibit Pf 29
Nov 15, 2024Exhibit Pf 28
Nov 15, 2024Exhibit Pf 27
Nov 15, 2024Exhibit Pf 26
Nov 15, 2024Exhibit Pf 25
Nov 15, 2024Exhibit Pf 24
Nov 15, 2024Exhibit Pf 23
Nov 15, 2024Exhibit Pf 22
Nov 15, 2024Exhibit Pf 21
Nov 15, 2024Exhibit Pf 20 Part 2
Nov 15, 2024Exhibit Pf 20 Part 1
Nov 15, 2024Exhibit Pf 14
Nov 15, 2024Exhibit Pf 13
Nov 15, 2024Exhibit Pf 12
Nov 15, 2024Exhibit Pf 12
Nov 15, 2024Exhibit Pf 11
Nov 15, 2024Exhibit Pf 11
Nov 15, 2024Exhibit Pf 10
Nov 15, 2024Exhibit Pf 10
Nov 15, 2024Epo Request For Case Pending
Nov 15, 2024Counterclaim For Revocation
Nov 15, 2024Acknowledgement Of Lodging
Nov 15, 2024Acknowledgement Of Access To Case

More cases involving EP4183412B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
CC_60908/2024Nov 14, 2024Laboratorios Pfizer, Pfizer, Pfizer Austria, Pfizer LuxembourgGlaxosmithkline
ACT_45928/2024Aug 14, 2024Pfizer, Pfizer Europe MA Eeig, Pfizer Manufacturing Belgium, Pfizer Pharma, Pfizer ServiceGlaxosmithkline
UPC_CFI_476/2024Aug 14, 2024Pfizer, Pfizer Europe MA Eeig, Pfizer Manufacturing Belgium, Pfizer Pharma, Pfizer ServiceGlaxosmithkline

More cases involving Laboratorios Pfizer

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_16366/2025Apr 10, 2025Laboratorios Pfizer -
ORD_12887/2025Mar 14, 2025Laboratorios PfizerGlaxosmithkline
APP_4496/2025Jan 28, 2025Laboratorios Pfizer -

More cases involving Glaxosmithkline

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_33242/2025Jul 21, 2025Glaxosmithkline -
APP_33256/2025Jul 21, 2025Glaxosmithkline -
APP_33285/2025Jul 21, 2025Glaxosmithkline -